Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Cleerly

Cleerly Unveils Groundbreaking Late-Breaking Clinical Trial Results Demonstrating AI-QCT’s Predictive Power for Women’s Cardiovascular Risk at ACC.25
From Cleerly
Via Business Wire
Cleerly to Present Late-Breaking Clinical Trial Results on Cardiovascular Risk in Women at ACC.25
From Cleerly
Via Business Wire
Cleerly Brings Advanced AI Heart Imaging to the American College of Cardiology’s Chicago Community Health Fair
From Cleerly
Via Business Wire
Bunkerhill Health and Cleerly Announce Strategic Partnership to Advance Noninvasive Cardiovascular Care
From Cleerly
Via Business Wire
Cleerly to Present Innovative Research on Age and Sex-Specific Coronary Artery Disease at AHA Scientific Sessions 2024
From Cleerly
Via Business Wire
Cleerly Presents Late-Breaking Research on AI-Enabled Quantitative CT Coronary Assessment for Predicting Major Adverse Cardiovascular Events at TCT 2024
From Cleerly
Via Business Wire
Cleerly Secures CPT Category I Code for AI-QCT Advanced Plaque Analyses
From Cleerly
Via Business Wire
Medicare Administrative Contractors Approve Coverage of Cleerly Heart Scans to Medicare Recipients
From Cleerly
Via Business Wire
Cleerly® ISCHEMIA™ Demonstrates Robust Diagnostic Accuracy and Prognostic Utility in Analyses from Large Scale Clinical Trials
From Cleerly
Via Business Wire
Cleerly® Receives FDA Breakthrough Device Designation for Heart Disease Risk Staging System
From Cleerly
Via Business Wire
Cleerly® ISCHEMIA™ Software Device Billable With AMA Category I CPT® Code for Noninvasive Estimates of Fractional Flow Reserve
From Cleerly
Via Business Wire
Cleerly® Announces CERTAIN Multicenter Clinical Trial Results
From Cleerly
Via Business Wire
Cleerly® Launches Cleerly® ISCHEMIA™ Solution for Heart Disease Analysis
From Cleerly
Via Business Wire
Cleerly, Partners Announce TRANSFORM Trial to Evaluate Personalized Heart Disease Care Strategies at American Heart Association 2023
From Cleerly
Via Business Wire
Cleerly Takes Center Stage as Best Use of AI in Health Tech Winner at the Fifth Annual Digital Health Hub Foundation Awards
From Cleerly
Via Business Wire
Cleerly Wins 2023 Artificial Intelligence Breakthrough Award
From Cleerly
Via Business Wire
Cleerly Expands Executive Team With Appointment of New Chief Financial Officer and Executive Vice President of Regulatory Affairs Positions
From Cleerly
Via Business Wire
Cleerly to Present New Clinical Evidence on AI-Enabled CCTA at ACC.23/WCC
From Cleerly
Via Business Wire
Cleerly Hires Udo Hoffmann, MD, MPH as Chief Scientific Officer
From Cleerly
Via Business Wire
Cleerly partners with Heartbeat Health in new heart disease detection program
From Cleerly
Via Business Wire
Cleerly Introduces Proxy Solution to Improve Heart Disease Imaging Workflows
From Cleerly
Via Business Wire
Heart Health Innovator Cleerly Appoints Joseph Jasser, MD, as Chief of Value Based Care
From Cleerly
Via Business Wire
Heart Health Innovator Cleerly Closes Series C Funding Round with $192 Million
From Cleerly
Via Business Wire
Cleerly Takes Precision Heart Care to the Next Level with Cleerly 2.2.0
From Cleerly
Via Business Wire
Cleerly Named to NYC Digital Health 100 by New York City Health Business Leaders
From Cleerly
Via Business Wire
Cleerly Expands Board of Directors with Three New Members
From Cleerly
Via Business Wire
Cleerly Appoints Jim Hartman as Chief Revenue Officer
From Cleerly
Via Business Wire
Cleerly Expands Executive Team With Appointment of New Chief Operating Officer and Chief Technology Officer
From Cleerly
Via Business Wire
Cleerly Launches with $43 Million Series B to Provide a New Standard of Care for the Leading Cause of Death – Heart Disease
From Cleerly
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.